PG
Publicaties op Oncologisch.com
Blaassparende strategieën bij spierinvasieve blaaskanker
Health-related quality of life with belzutifan versus everolimus for gevorderd renal cell carcinoma (LITESPARK-005): ...
Fase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1).
Belzutifan versus everolimus bij gevorderd RCC: LITESPARK-005 fase III